September 14, 2017Neurology
Relevance of supraventricular runs detected after cerebral ischemia
Key result
Supraventricular runs detected after acute cerebral ischemia were associated with more recurrent strokes (p=0.04) and numerically more novel AF (12% vs 5%) over 3.7 years compared to controls.
Why the study?
Does the presence of supraventricular runs detected by prolonged Holter ECG after cerebral ischemia predict recurrent strokes and novel atrial fibrillation?
Population
254 patients with acute cerebral ischemia, mean age 70.0 years, 45.3% female.
Comparison
Detection of supraventricular runs via 7-day… vs Patients without SV runs on 7-day Holter ECG…
Design
Cohort
Follow-up
mean 3.7 years
Authors
Discussion
Loading...
Member takes
Implication
May support extended monitoring after cerebral ischemia; leaves open whether targeted intervention reduces recurrent stroke.
Study Design
Type
Cohort (n=254)
Structured PICO
Does the presence of supraventricular runs detected by prolonged Holter ECG after cerebral ischemia predict recurrent strokes and novel atrial fibrillation?
P
Population
254 patients with acute cerebral ischemia, mean age 70.0 years, followed for a mean of 3.7 years.
E
Exposure
Detection of supraventricular (SV) runs (>5 beats but <30 seconds in a 24-hour ECG interval) via 7-day Holter ECG monitoring
C
Comparator
Patients without SV runs (controls) on 7-day Holter ECG monitoring
O
Outcome
Recurrent strokes and novel atrial fibrillation during long-term follow-uphard clinical
Main Result
p-value: p=0.04
Supraventricular runs detected after cerebral ischemia are associated with a higher risk of recurrent strokes, suggesting these patients may benefit from further prolonged ECG monitoring.
Cite This Study
Weber-Krüger et al. (2017) conducted a cohort in Acute cerebral ischemia (n=254). Supraventricular (SV) runs vs. Patients without SV runs (controls) was evaluated on Recurrent strokes (p=0.04). Supraventricular runs detected after acute cerebral ischemia were associated with more recurrent strokes (p=0.04) and numerically more novel AF (12% vs 5%) over 3.7 years compared to controls.